DCGI Current Affairs, GK & News

2DG- DRDO’s Anti-Covid Drug

On May 17, 2021, the DRDO released the first batch of 2-DG drugs. The 2-DG was developed by the Defence Research Development Organisation for Emergency Use. 2-DG is 2-Deoxy – D – Glucose. It is to be provided as a supplementary. Around 10,000 doses are to be launched first. It was developed in collaboration with ..

Month: 

Category: 

Topics: 

Indian Company Zydus Cadila Starts Clinical Trial for COVID 19 Vaccine

The Indian pharmaceutical behemoth, Zydus Cadila, has started the Phase I, II clinical trials for its COVID 19 vaccine. The pharma giant had received approval from the Drug Controller General of India for clinical trials earlier this month. The company has started its trial with 1048 subjects by intradermal injection route. The Clinical Trial Registry ..

Month: 

Category: 

Topics: 

First indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine Approved by DCGI

The first-ever completely home-grown Pneumococcal Polysaccharide Conjugate Vaccine has been approved by the Drug Controller General of India. The vaccine has been developed by Serum Institute of India, Pune. Serum Institute of India is also involved in the development of COVID 19 vaccine. The DCGI had given approval earlier to Serum Institute of India to ..

Month: 

Category: 

Topics: 

DCGI allows use of “Itolizumab” for moderate to severe COVID-19 cases

On July 11, 2020, the Dugs Controller General of India (DCGI) granted restricted emergency use of Itolizumab for moderate to severe COVI-19 patients. Highlights Itolizumab is a monoclonal antibody that was already approved for chronic plaque psoriasis. The drug will now be used to treat COVID-19 based on clinical trials. The drug was manufactured and ..

Month: 

Category: 

Topics: 

CSIR: Clinical Trial of “Sepsivac” drug on critically ill COVID-19 patients

On April 22, 2020, the Council of Scientific and Industrial Research announced that it is to go for clinical trials on critically ill COVID-19 patients. Background The Drugs Controller General of India recently approved the trial of “Sepsivac”. The drug is available commercially. With the DCGI approving the drug, CSIR is to start clinical trials ..

Month: 

Category: 

Topics: